Our News
CN Bio launches PhysioMimix benchtop Human-Body-on-a-Chip device
London, UK, 23 May 2018: CN Bio Innovations Limited today launched PhysioMimix, a printer-sized device which allows scientist to conduct organ-on-chip studies in their own labs, testing new drugs and chemicals on living human organ models. Dr Emma Sceats, CEO of CN...
Radio 4’s PM features CN Bio Human Organ-on-Chips
Listen to Radio 4’s flagship PM programme with Caroline Quinn interview CN Bio Innovations’ CEO Dr Emma Sceats. Emma describes London-based CN Bio’s organ-on-chips: miniature devices that help researchers re-create the structure and function of human organs in the...
CN Bio and MIT announce 10 Organ-On-Chip Platform: Nature Scientific Reports
Organ-on-Chip specialist CN Bio's microfluidic platform for improving drug evaluation has taken a significant step forward. CN Bio's partners at MIT today published details of the platform which successfully connects engineered tissues from up to 10 organs, accurately...
CN Bio MicroMix to be featured at AACR
Dr David Hughes, Chief Technical Officer at Organ-on-Chip specialist CN Bio Innovations will be presenting a poster at the American Association for Cancer Research Annual Meeting 2018. The poster will cover the company’s MicroMix technology. MicroMix uses pumps and...
PharmaVentures Interview: Will Organ-on-Chip technology provide the data Regulators need in the future?
As new drug treatments are developed, quicker and much more precise technology which predicts the effect these chemical and biological substances have on human organs are also becoming available. These technologies will be important particularly for pharmaceutical and...
Hepatitis B research using CN Bio Organ-on-Chips published in Nature Communications
London, UK, February 15 2018: In an article published in Nature Communications scientists at Imperial College London have demonstrated how pathogens interact with human organ mimics. The Organ-on-Chip technology used for the studies was an artificial liver -...
R&D 100 Award won by Vanderbilt team for tech being developed with CN Bio
A cell-culture technology now being developed by London biotech CN Bio Innovations and its global pharmaceutical company partner, has won one of the scientific world's premier awards - known as the "Oscars of Innovation". A team of Vanderbilt University scientists and...
CN Bio Innovations announces research collaboration with AstraZeneca to validate a new in vitro tool to predict optimised drug dosing regimens for multi-drug therapies
London, UK, November 1 2017: Organ-on-a-Chip specialist CN Bio Innovations Limited announces a research collaboration with global biopharmaceutical company AstraZeneca to validate a new in vitro research tool that enables the high throughput evaluation of multi-drug...
FDA signs collaborative agreement with CN Bio Innovations to use Organs-on-Chips to improve drug development and evaluation
London, UK, October 26 2017: CN Bio Innovations Limited announced today that it has entered into a Research Collaboration Agreement with the US Food and Drug Administration’s (FDA) Center for Drug Evaluation and Research. FDA and CN Bio will collaborate to...
Innovate UK awards grant to CN Bio Innovations and AstraZeneca to use Organs-on-Chips to evaluate the use of existing drugs to treat fatty liver disease
London, UK, October 11 2017: Organ-on-a-Chip specialist CN Bio Innovations Limited announces that Innovate UK has awarded the company a £670,000 grant co-funded by the newly created Industrial Strategy Challenge Fund. Under the award, CN Bio will collaborate with...